SCHEMBL3332845

SCHEMBL3332845

O=C(O)c1ccc(Cl)nc1NCc1ccccn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SORT1 Q99523 1/20 0.48
HPGD P15428 4/20 0.48
ALDH1A1 P00352 2/20 0.48
MAOA P21397 1/20 0.48
MAOB P27338 1/20 0.48
PLAU P00749 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CSNK2A1 P68400 2/20 0.46
JAK2 O60674 1/20 0.46
IGF1R P08069 1/20 0.46
PIM1 P11309 1/20 0.46
SRC P12931 1/20 0.46
CSNK2A2 P19784 1/20 0.46
KCNA5 P22460 1/20 0.46
JAK1 P23458 1/20 0.46
CCNE1 P24864 1/20 0.46
CDK2 P24941 1/20 0.46
TYK2 P29597 1/20 0.46
FLT4 P35916 1/20 0.46
FLT3 P36888 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3332328 0.88 HPGD (0.49) SORT1HPGDALDH1A1MAOAMAOB
SCHEMBL1573565 0.77 MAOA (0.45) HPGDALDH1A1MAOAMAOBPLAU
SCHEMBL1573567 0.77 KDM4E (0.47) HPGDALDH1A1MAOAMAOBPLAU
SCHEMBL3055165 0.77 KDM5B (0.49) SORT1PLAUCSNK2A1PPARGKDM4E
SCHEMBL7461503 0.76 HPGD (0.60) SORT1HPGDALDH1A1MAOAMAOB
SCHEMBL5301989 0.75 MAPT (0.55) HPGDALDH1A1MAOAMAOBPLAU
SCHEMBL29664470 0.75 MAOA (0.56) SORT1HPGDALDH1A1MAOAMAOB
SCHEMBL18394876 0.75 MAOA (0.56) SORT1HPGDALDH1A1MAOAMAOB
SCHEMBL22261121 0.74 JAK3 (0.57) HPGDALDH1A1MAOAMAOBPLAU
SCHEMBL29622856 0.74 JAK3 (0.57) HPGDALDH1A1MAOAMAOBPLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8470847-B2 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics SANOFI (FR) 2013-06-25 US disclosed
US-20100144757-A1 DERIVATIVES OF 7-ALKYNYL-1,8-NAPHTHYRIDONES, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS SANOFI-AVENTIS (FR) 2010-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144757-A1 DERIVATIVES OF 7-ALKYNYL-1,8-NAPHTHYRIDONES, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS ALK, ABL1, SMPD1 SORT1 532/4885HPGD 2334/4885ALDH1A1 40/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.